CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.21 USD
+0.02 (1.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.20 -0.01 (-0.83%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Earnings News For CTMX
-
CytomX Therapeutics: Q2 Earnings Snapshot
-
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
CytomX Therapeutics: Q1 Earnings Snapshot
-
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
CytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates
-
CytomX (CTMX) to Report Q4 Earnings: Here's What to Expect
-
CytomX Therapeutics: Q3 Earnings Snapshot
-
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
CytomX Therapeutics (CTMX) Reports Q2 Loss, Tops Revenue Estimates
-
CytomX Therapeutics: Q2 Earnings Snapshot
-
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates
-
CytomX Therapeutics: Q1 Earnings Snapshot
-
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
Will CytomX Therapeutics (CTMX) Report Negative Q1 Earnings? What You Should Know
-
CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates
-
CytomX Therapeutics (CTMX) Reports Q3 Loss, Misses Revenue Estimates
-
CytomX Therapeutics: Q3 Earnings Snapshot
-
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates
-
CytomX Therapeutics: Q2 Earnings Snapshot
-
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
-
CytomX Therapeutics (CTMX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
CytomX Therapeutics (CTMX) Reports Q1 Loss, Lags Revenue Estimates
-
CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates